Combinatorial activities of ionic silver and sodium hexametaphosphate against microorganisms associated with chronic wounds

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2556-2561

  Humphreys, Gavin ^a   Lee, Guat Ling ^a   Percival, Steven L ^b,c   McBain, Andrew J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Advanced Medical Solutions   (United Kingdom)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biofilms; CDC biofilm reactor; Fractional biofilm eradication concentration index; Fractional inhibitory concentration index; Hydrogels

Indexed keywords

HEXAMETAPHOSPHATE SODIUM; SILVER NITRATE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; BROTH DILUTION; CANDIDA ALBICANS; CHRONIC WOUND; FRACTIONAL BIOFILM ERADICATION CONCENTRATION INDEX; FRACTIONAL INHIBITORY CONCENTRATION INDEX; HYDROGEL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BIOFILMS; CANDIDA ALBICANS; HYDROGELS; MICROBIAL SENSITIVITY TESTS; PHOSPHATES; PLANKTON; PSEUDOMONAS AERUGINOSA; SILVER; STAPHYLOCOCCUS AUREUS; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 80054679291     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr350     Document Type: Article

References (44)

1. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-46.
2. van Anholt RD, Sobotka L, Meijer EP et al. Specific nutritional support accelerates pressure ulcer healing and reduces wound care intensity in non-malnourished patients. Nutrition 2010; 9: 867-72.
3. Rezvani O, Shabbak E, Aslani A et al. A randomized, double-blind, placebo-controlled trial to determine the effects of topical insulin on wound healing. Ostomy Wound Manage 2009; 55: 22-8.
4. von Smitten K, Sundell B. The impact of adjuvant radiotherapy and cytotoxic chemotherapy on the outcome of immediate breast reconstruction by tissue expansion after mastectomy for breast cancer. Eur J Surg Oncol 1992; 18: 119-23.
5. Jorgensen LN, Kallehave F, Christensen E et al. Less collagen production in smokers. Surgery 1998; 123: 450-5.
6. Wolcott RD, Gontcharova V, Sun Y et al. Bacterial diversity in surgical site infections: not just aerobic cocci any more. J Wound Care 2009; 18: 317-23.
7. Dowd SE, Delton Hanson J, Rees E et al. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care 2011; 20: 40-7.
8. Bjarnsholt T, Kirketerp-Moller K, Jensen PO et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2-10.
9. Gilbert P, McBain AJ. Biofilms: their impact on health and their recalcitrance toward biocides. Am J Infect Control 2001; 29: 252-5.
10. Robson MC, Edstrom LE, Krizek TJ et al. The efficacy of systemic antibiotics in the treatment of granulating wounds. J Surg Res 1974; 16: 299-306.
11. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14: 244-69.
12. Rhoads DD, Wolcott RD, Percival SL. Biofilms in wounds: management strategies. J Wound Care 2008; 17: 502-8.
13. Cullen B, Smith R, McCulloch E et al. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002; 10: 16-25.
14. Clement JL, Jarrett PS. Antibacterial silver. Met Based Drugs 1994; 1: 467-82.
15. Akhtar S, Paredes-SabjaD, SarkerMR. Inhibitory effects of polyphosphates on Clostridium perfringens growth, sporulation and spore outgrowth. Food Microbiol 2008; 25: 802-8.
16. Obritsch JA, Ryu D, Lampila LE et al. Antibacterial effects of long-chain polyphosphates on selected spoilage and pathogenic bacteria. J Food Prot 2008; 71: 1401-5.
17. Lee RM, Hartman PA, Olson DG et al. Bactericidal and bacteriolytic effects of selected food-grade phosphates, using Staphylococcus aureus as a model system. J Food Prot 1994; 8: 276-83.
18. Ong SY, Wu J, Moochhala SM et al. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 2008; 29: 4323-32.
19. McBain AJ. Chapter 4: In vitro biofilm models: an overview. Adv Appl Microbiol 2009; 69: 99-132.
20. Donlan RM, Piede JA, Heyes CD et al. Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol 2004; 70: 4980-8.
21. Goeres DM, Loetterle LR, Hamilton MA et al. Statistical assessment of a laboratory method for growing biofilms. Microbiology 2005; 151: 757-62.
22. Frade JP, Arthington-Skaggs BA. Effect of serum and surface characteristics on Candida albicans biofilm formation. Mycoses 2011; 54: e154-62.
23. Gilmore BF, Hamill TM, Jones DS et al. Validation of the CDC biofilm reactor as a dynamic model for assessment of encrustation formation on urological device materials. J Biomed Mater Res B Appl Biomater 2010; 93: 128-40.
24. Williams DL, Bloebaum RD. Observing the biofilm matrix of Staphylococcus epidermidis ATCC 35984 grown using the CDC biofilm reactor. Microsc Microanal 2010; 16: 143-52.
25. Buckingham-Meyer K, Goeres DM, Hamilton MA. Comparative evaluation of biofilm disinfectant efficacy tests. J Microbiol Methods 2007; 70: 236-44.
26. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
27. Ceri H, Olson ME, Stremick C et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-6.
28. Orhan G, Bayram A, Zer Y et al. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol 2005; 43: 140-3.
29. Vaara M, Siikanen O, Apajalahti J et al. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Antimicrob Agents Chemother 2010; 54: 3341-6.
30. Petersen PJ, Labthavikul P, Jones CH et al. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 2006; 57: 573-6.
31. Moskowitz SM, Foster JM, Emerson J et al. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004; 42: 1915-22.
32. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009; 37: 1528-42.
33. Gilbert P, Maira-Litran T, McBain AJ et al. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 2002; 46: 202-56.
34. Percival SL, Bowler PG, Dolman J. Antimicrobial activityof silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007; 4: 186-91.
35. Wu J, Hou S, Ren D et al. Antimicrobial properties of nanostructured hydrogel webs containing silver. Biomacromolecules 2009; 10: 2686-93.
36. Shirashoji N, Jaeggi JJ, Lucey JA. Effect of sodium hexametaphosphate concentration and cooking time on the physicochemical properties of pasteurized process cheese. J Dairy Sci 2010; 93: 2827-37.
37. Maier SK, Scherer S, Loessner MJ. Long-chain polyphosphate causes cell lysis and inhibits Bacillus cereus septum formation, which is dependent on divalent cations. Appl Environ Microbiol 1999; 65: 3942-9.
38. Vaara M, Jaakkola J. Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas, and Escherichia coli to hydrophobic drugs. Antimicrob Agents Chemother 1989; 33: 1741-7.
39. RayChaudhuri D, Park JT. Escherichia coli cell-division gene ftsZ encodes a novel GTP-binding protein. Nature 1992; 359: 251-4.
40. Feng QL, Wu J, Chen GQ et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000; 52: 662-8.
41. Crumplin GC, Smith JT. Nalidixic acid: an antibacterial paradox. Antimicrob Agents Chemother 1975; 8: 251-61.
42. Olitzky I. Antimicrobial properties of a propylene glycol based topical therapeutic agent. J Pharm Sci 1965; 54: 787-8.
43. Smith SA, Morrissey JH. Polyphosphate enhances fibrin clot structure. Blood 2008; 112: 2810-6.
44. Edwards JV, Howley PS. Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings. J Biomed Mater Res A 2007; 83: 446-54.